Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

3.1K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

889
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
889

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melatonin Targets Mitochondrial Redox Homeostasis: Optimizing the Intracellular Microenvironment.

International journal of molecular sciences·2026
Same author

Antioxidant activity at the molecular level: exploring ways of action and computational tools to investigate them.

Chemical science·2025
Same author

A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Antioxidants: The Chemical Complexity Behind a Simple Word.

Accounts of chemical research·2025
Same author

Adsorption of procarbazine anticancer drug over C<sub>24</sub> and B<sub>12</sub>N<sub>12</sub> nanocages: A comparative DFT study.

Journal of molecular graphics & modelling·2025
Same author

Computer-aided design of caffeic acid derivatives: free radical scavenging activity and reaction force.

Journal of molecular modeling·2024

Related Experiment Video

Updated: Jul 12, 2025

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.5K

Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential.

Luis Felipe Hernández-Ayala1, Eduardo Gabriel Guzmán-López1, Annia Galano1

  • 1Departamento de Química, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril San Rafael Atlixco 186, Col. Leyes de Reforma 1A Sección, Alcaldía Iztapalapa, México City 09310, Mexico.

Antioxidants (Basel, Switzerland)
|October 28, 2023
PubMed
Summary

Researchers designed 8536 quinoline derivatives, identifying four promising candidates for multifunctional antioxidants. These compounds show potential for treating neurodegenerative diseases like Alzheimer's and Parkinson's.

Keywords:
Alzheimer and Parkinson diseasesantioxidantsneuroprotectionquinoline derivativesrational design

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.6K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.3K

Related Experiment Videos

Last Updated: Jul 12, 2025

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.5K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.6K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.3K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Neuroscience

Background:

  • Quinoline derivatives are recognized for diverse biological activities.
  • Designing novel quinoline compounds is crucial for drug discovery.
  • Understanding structure-activity relationships enhances therapeutic potential.

Purpose of the Study:

  • To design and screen a large library of quinoline derivatives for medicinal applications.
  • To evaluate the acid-base, antioxidant, and neuroprotective properties of selected derivatives.
  • To identify novel multifunctional antioxidants for neurodegenerative diseases.

Main Methods:

  • Utilized the CADMA-Chem protocol for strategic design of 8536 quinoline derivatives.
  • Employed selection and elimination scores based on bioavailability, toxicity, and manufacturability.
  • Predicted antioxidant activity using ionization potential and bond dissociation energies; assessed neuroprotection via molecular docking.

Main Results:

  • Identified 25 quinoline derivatives with promising properties after extensive filtering.
  • Antioxidant efficiency varied, with some derivatives outperforming Trolox but not ascorbate.
  • Molecular docking suggested potential inhibition of key enzymes (COMT, AChE, MAO-B) implicated in neurodegeneration.

Conclusions:

  • Four quinoline derivatives demonstrated potential as multifunctional antioxidants.
  • These candidates show promise for combating Alzheimer's and Parkinson's diseases.
  • Structural insights provide a basis for further optimization of neuroprotective agents.